iTeos Therapeutics, Inc. Profile Avatar - Palmy Investing

iTeos Therapeutics, Inc.

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine…

Biotechnology
US, Cambridge [HQ]

Balance Sheet

Loading...
End of ITOS's Analysis
CIK: 1808865 CUSIP: 46565G104 ISIN: US46565G1040 LEI: - UEI: -
Secondary Listings
ITOS has no secondary listings inside our databases.